Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.
暂无分享,去创建一个
A. F. Stewart | A. Broadus | W. Burtis | K. Insogna | T. Wu | M. Mangin | Andrew F. Stewart | D. Goumas | Terence Wu | T. Wu
[1] P. Barrett,et al. Synthetic and partially-purified adenylate cyclase-stimulating proteins from tumors associated with humoral hypercalcemia of malignancy inhibit phosphate transport in a PTH-responsive renal cell line. , 1988, The Journal of clinical endocrinology and metabolism.
[2] A. Broadus,et al. Two forms of parathyroid hormone‐like adenylate cyclase‐stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] E. Chen,et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. , 1987, Science.
[4] A. F. Stewart,et al. Skin-derived fibroblasts respond to human parathyroid hormone-like adenylate cyclase-stimulating proteins. , 1987, The Journal of clinical endocrinology and metabolism.
[5] L. Suva,et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. F. Stewart,et al. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. , 1987, The Journal of biological chemistry.
[7] A. Tashjian,et al. Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. , 1987, Endocrinology.
[8] A. F. Stewart,et al. Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy. , 1987, Endocrinology.
[9] G. Strewler,et al. Parathyroid hormone-like adenylate cyclase-stimulating activity from a human carcinoma is associated with bone-resorbing activity. , 1987, Endocrinology.
[10] S. Nussbaum,et al. Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Rizzoli,et al. Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats. , 1986, Endocrinology.
[12] A. F. Stewart,et al. Frequency and partial characterization of adenylate cyclase‐stimulating activity in tumors associated with humoral hypercalcemia of malignancy , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] S. Rabbani,et al. Purification of peptides with parathyroid hormone-like bioactivity from human and rat malignancies associated with hypercalcemia. , 1986, Endocrinology.
[14] T. Bringman,et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.
[15] A. F. Stewart,et al. A parathyroid hormone-like protein from cultured human keratinocytes. , 1986, Science.
[16] R. Derynck,et al. Human transforming growth factor-alpha stimulates bone resorption in vitro. , 1985, The Journal of clinical investigation.
[17] G. Strewler,et al. Activation of the parathyroid hormone receptor-adenylate cyclase system in osteosarcoma cells by a human renal carcinoma factor. , 1985, Cancer research.
[18] F. Dewhirst,et al. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. , 1985, Journal of immunology.
[19] C. Silve,et al. A factor produced by cultured rat Leydig tumor (Rice 500) cells associated with humoral hypercalcemia stimulates adenosine 3',5'-monophosphate production via the parathyroid hormone receptor in human skin fibroblasts. , 1985, The Journal of clinical endocrinology and metabolism.
[20] J. Habener,et al. Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. , 1984, Physiological reviews.
[21] Gideon,et al. Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. , 1983, The Journal of clinical investigation.
[22] A. F. Stewart,et al. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[23] G. Strewler,et al. Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. , 1983, The Journal of clinical investigation.
[24] R. Baron,et al. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. , 1982, The Journal of clinical endocrinology and metabolism.
[25] F. Singer,et al. Abnormal bone and parathyroid histology in carcinoma patients with pseudohyperparathyroidism , 1982, Cancer.
[26] A. F. Stewart,et al. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. , 1980, The New England journal of medicine.
[27] J. Potts,et al. Parathyroid hormone inhibitors. Design, synthesis, and biologic evaluation of hormone analogues. , 1977, The Journal of biological chemistry.
[28] G. Carpenter,et al. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy. , 1985, Endocrinology.
[29] L. Raisz. BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. , 1965, The Journal of clinical investigation.